Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02168179
What this trial is testing

KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituSkin Reactions Secondary to Radiation TherapyStage IA Breast Cancer+4 more
Wake Forest University Health Sciences
Not applicableUnknownNCT01064427
What this trial is testing

Factors Correlated With Fatigue in Breast Cancer

Who this might be right for
Newly Diagnosed Breast CancerSurgery Programmed
Central Hospital, Nancy, France 557
Not applicableStudy completedNCT05269342
What this trial is testing

Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer

Who this might be right for
Head and Neck CancerCancer of Head and NeckHead and Neck Neoplasms
YU LONG HONG 40
Not applicableStudy completedNCT00618813
What this trial is testing

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Who this might be right for
Ewing Sarcoma of BoneLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Children's Oncology Group 35
Testing effectiveness (Phase 2)Study completedNCT02044796
What this trial is testing

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+3 more
Fred Hutchinson Cancer Center 199
Testing effectiveness (Phase 2)Study completedNCT00376961
What this trial is testing

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 68
Testing effectiveness (Phase 2)Study completedNCT02441686
What this trial is testing

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Study completedNCT00290498
What this trial is testing

Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 67
Testing effectiveness (Phase 2)UnknownNCT04874506
What this trial is testing

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Matrix Biomed, Inc. 55
Large-scale testing (Phase 3)Looking for participantsNCT07203352
What this trial is testing

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Nanfang Hospital, Southern Medical University 154
Testing effectiveness (Phase 2)Study completedNCT01237249
What this trial is testing

Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 250
Large-scale testing (Phase 3)Looking for participantsNCT07297329
What this trial is testing

Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Multiple Myeloma (MM)
Sinocelltech Ltd. 292
Testing effectiveness (Phase 2)Study completedNCT02655601
What this trial is testing

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Who this might be right for
High Grade GliomaAstrocytoma, Grade IIIGlioblastoma
BioMimetix JV, LLC 177
Testing effectiveness (Phase 2)Looking for participantsNCT05843253
What this trial is testing

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+7 more
Nationwide Children's Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03701295
What this trial is testing

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Study completedNCT00112931
What this trial is testing

Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University College, London 462
Large-scale testing (Phase 3)Not Yet RecruitingNCT06477939
What this trial is testing

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

Who this might be right for
Glioblastoma
Institut de cancérologie Strasbourg Europe 554
Large-scale testing (Phase 3)Study completedNCT00002995
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 483
Testing effectiveness (Phase 2)WithdrawnNCT03764137
What this trial is testing

Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer

Who this might be right for
Metastatic Colon Cancer
University of Alabama at Birmingham
Large-scale testing (Phase 3)WithdrawnNCT00334867
What this trial is testing

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group
Next Page